Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Pathophysiology, Nanjing Medical University, Nanjing 211166, China.
Acta Pharmacol Sin. 2018 Jan;39(1):74-84. doi: 10.1038/aps.2017.129. Epub 2017 Oct 12.
Acetaminophen (APAP) overdose leads to severe hepatotoxicity. Osthole, a natural coumarin found in traditional Chinese medicinal herbs, has therapeutic potential in the treatment of various diseases. In this study, we investigated the effects of osthole against APAP-induced hepatotoxicity in mice. Mice were administered osthole (100 mg·kg·d, ip) for 3 d, then on the fourth day APAP (300 mg/kg, ip) was co-administered with osthole. The mice were euthanized post-APAP, their serum and livers were collected for analysis. Pretreatment with osthole significantly attenuated APAP-induced hepatocyte necrosis and the increases in ALT and AST activities. Compared with the mice treated with APAP alone, osthole pretreatment significantly reduced serum MDA levels and hepatic HO levels, and improved liver GSH levels and the GSSG-to-GSH ratio. Meanwhile, osthole pretreatment markedly alleviated the APAP-induced up-regulation of inflammatory cytokines in the livers, and inhibited the expression of hepatic cytochrome P450 enzymes, but it increased the expression of hepatic UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs). Furthermore, osthole pretreatment reversed APAP-induced reduction of hepatic cAMP levels, but pretreatment with H89, a potent selective PKA inhibitor, failed to abolish the beneficial effect of osthole, whereas pretreatment with L-buthionine sulfoximine, a GSH synthesis inhibitor, abrogated the protective effects of osthole on APAP-induced liver injury, and abolished osthole-caused alterations in APAP-metabolizing enzymes. In cultured murine primary hepatocytes and Raw264.7 cells, however, osthole (40 μmol/L) did not alleviate APAP-induced cell death, but it significantly suppressed APAP-caused elevation of inflammatory cytokines. Collectively, we have demonstrated that osthole exerts a preventive effect against APAP-induced hepatotoxicity by inhibiting the metabolic activation of APAP and enhancing its clearance through an antioxidation mechanism.
对乙酰氨基酚(APAP)过量会导致严重的肝毒性。奥沙托品,一种天然香豆素,存在于传统中药中,具有治疗各种疾病的潜力。在这项研究中,我们研究了奥沙托品对小鼠 APAP 诱导的肝毒性的影响。小鼠连续 3 天腹腔注射奥沙托品(100mg·kg·d),第四天同时给予 APAP(300mg/kg,腹腔注射)。APAP 处理后,处死小鼠,收集血清和肝脏进行分析。奥沙托品预处理显著减轻了 APAP 诱导的肝细胞坏死和 ALT 和 AST 活性升高。与单独用 APAP 处理的小鼠相比,奥沙托品预处理显著降低了血清 MDA 水平和肝 HO 水平,改善了肝 GSH 水平和 GSSG-GSH 比值。同时,奥沙托品预处理显著减轻了 APAP 诱导的肝脏炎症细胞因子的上调,并抑制了肝细胞色素 P450 酶的表达,但增加了肝 UDP-葡糖醛酸转移酶(UGTs)和磺基转移酶(SULTs)的表达。此外,奥沙托品预处理逆转了 APAP 诱导的肝 cAMP 水平降低,但用 PKA 选择性抑制剂 H89 预处理不能消除奥沙托品的有益作用,而用 GSH 合成抑制剂 L-丁硫氨酸亚砜胺预处理则消除了奥沙托品对 APAP 诱导的肝损伤的保护作用,并消除了奥沙托品引起的 APAP 代谢酶的改变。然而,在培养的小鼠原代肝细胞和 Raw264.7 细胞中,奥沙托品(40μmol/L)并没有减轻 APAP 诱导的细胞死亡,但它显著抑制了 APAP 引起的炎症细胞因子的升高。总的来说,我们已经证明,奥沙托品通过抑制 APAP 的代谢激活和通过抗氧化作用增强其清除来发挥预防 APAP 诱导的肝毒性的作用。